Q32 Bio Inc (United States) is listed on the Nasdaq and has a market capitalization of $327.20 million, with shareholders equity totaling $105.91 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Q32 Bio Inc reported $- in revenue, generating net income of $33.78 million.
Key financial metrics include a P/E ratio of 9.69, a price-to-book (P/B) ratio of 3.09, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker QTTB.